SCHEMBL7228249

SCHEMBL7228249

N#CC1CC[CH]c2ccccc21

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4607686 0.72 CHRNB4 (0.36)
SCHEMBL25378607 0.69 CYP19A1 (0.36)
SCHEMBL14697151 0.69 MAOA (0.31)
SCHEMBL20768167 0.69
SCHEMBL15049692 0.69 MAOA (0.31)
SCHEMBL15049597 0.69 MAOA (0.31)
SCHEMBL9521913 0.69 ATM (0.36) ATM
SCHEMBL1697825 0.68 IDO1 (0.46)
Hydrochloric Acid SCHEMBL20843623 0.67 IDO1 (0.47)
SCHEMBL779498 0.65 IDO1 (0.49)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6608082-B1 Treatment of erectile dysfunction using isoquinoline compound melanocortin receptor ligands LION BIOSCIENCE AG (DE) 2003-08-19 US disclosed